Van Loon JE - Search Results

1

Antithrombin levels are associated with the risk of first and recurrent arterial thromboembolism at a young age.

Croles FN, Van Loon JE, Dippel DWJ, De Maat MPM, Leebeek FWG. Croles FN, et al. Among authors: van loon je. Atherosclerosis. 2018 Feb;269:144-150. doi: 10.1016/j.atherosclerosis.2018.01.014. Epub 2018 Jan 16. Atherosclerosis. 2018. PMID: 29366986 Free article.

2

Effect of genetic variations in syntaxin-binding protein-5 and syntaxin-2 on von Willebrand factor concentration and cardiovascular risk.

van Loon JE, Leebeek FW, Deckers JW, Dippel DW, Poldermans D, Strachan DP, Tang W, O'Donnell CJ, Smith NL, de Maat MP. van Loon JE, et al. Circ Cardiovasc Genet. 2010 Dec;3(6):507-12. doi: 10.1161/CIRCGENETICS.110.957407. Circ Cardiovasc Genet. 2010. PMID: 21156930 Free PMC article.

3

Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review.

van Schie MC, van Loon JE, de Maat MP, Leebeek FW. van Schie MC, et al. Among authors: van loon je. J Thromb Haemost. 2011 May;9(5):899-908. doi: 10.1111/j.1538-7836.2011.04243.x. J Thromb Haemost. 2011. PMID: 21342431 Free article. Review.

4

Relationship between thrombospondin gene variations, von Willebrand factor levels and the risk of coronary heart disease in an older population.

van Loon JE, de Maat MP, Hofman A, Witteman JC, Leebeek FW. van Loon JE, et al. J Thromb Haemost. 2011 Jul;9(7):1415-7. doi: 10.1111/j.1538-7836.2011.04314.x. J Thromb Haemost. 2011. PMID: 21518247 Free article. No abstract available.

5

The in vitro effect of the new antithrombotic drug candidate ALX-0081 on blood samples of patients undergoing percutaneous coronary intervention.

van Loon JE, de Jaegere PP, Ulrichts H, van Vliet HH, de Maat MP, de Groot PG, Simoons ML, Leebeek FW. van Loon JE, et al. Thromb Haemost. 2011 Jul;106(1):165-71. doi: 10.1160/TH10-12-0804. Epub 2011 Jun 9. Thromb Haemost. 2011. PMID: 21655675

6

von Willebrand factor plasma levels, genetic variations and coronary heart disease in an older population.

van Loon JE, Kavousi M, Leebeek FW, Felix JF, Hofman A, Witteman JC, de Maat MP. van Loon JE, et al. J Thromb Haemost. 2012 Jul;10(7):1262-9. doi: 10.1111/j.1538-7836.2012.04771.x. J Thromb Haemost. 2012. PMID: 22568520 Free article.

7

Effect of genetic variation in STXBP5 and STX2 on von Willebrand factor and bleeding phenotype in type 1 von Willebrand disease patients.

van Loon JE, Sanders YV, de Wee EM, Kruip MJ, de Maat MP, Leebeek FW. van Loon JE, et al. PLoS One. 2012;7(7):e40624. doi: 10.1371/journal.pone.0040624. Epub 2012 Jul 6. PLoS One. 2012. PMID: 22792389 Free PMC article.

8

Prognostic markers in young patients with premature coronary heart disease.

van Loon JE, de Maat MP, Deckers JW, van Domburg RT, Leebeek FW. van Loon JE, et al. Atherosclerosis. 2012 Sep;224(1):213-7. doi: 10.1016/j.atherosclerosis.2012.06.067. Epub 2012 Jul 7. Atherosclerosis. 2012. PMID: 22818563 Free article.

9

Relationship of Von Willebrand Factor with carotid artery and aortic arch calcification in ischemic stroke patients.

Sonneveld MA, van Dijk AC, van den Herik EG, van Loon JE, de Lau LM, van der Lugt A, Koudstaal PJ, de Maat MP, Leebeek FW. Sonneveld MA, et al. Among authors: van loon je. Atherosclerosis. 2013 Oct;230(2):210-5. doi: 10.1016/j.atherosclerosis.2013.07.046. Epub 2013 Aug 2. Atherosclerosis. 2013. PMID: 24075746 Free article.

10

van Loon JE, Sonneveld MA, Praet SF, de Maat MP, Leebeek FW. van Loon JE, et al. PLoS One. 2014 Mar 13;9(3):e91687. doi: 10.1371/journal.pone.0091687. eCollection 2014. PLoS One. 2014. PMID: 24626470 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters